C. Ryan Oliver

Dr. C. Ryan Oliver

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2019 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
C. Ryan OliverC. Ryan Oliver
C. Ryan Oliver
MAMegan A. Altemus
Megan A. Altemus
TWTrisha M. Westerhof
Trisha M. Westerhof
HCHannah Cheriyan
Hannah Cheriyan
XCXu Cheng
Xu Cheng
SMSofia Merajver
Sofia Merajver
Brain metastases are the most lethal complication of advanced cancer; therefore, it is critical to identify when a tumor has the potential to metastasize to the brain.

5 February 2023 in Advanced NanoBiomed Research
Verified
Journal Article
Open access
PDF file
TWTrisha M. Westerhof
Trisha M. Westerhof
BYBenjamin A. Yang
Benjamin A. Yang
NMNathan M. Merrill
Nathan M. Merrill
JYJoel A. Yates
Joel A. Yates
MAMegan Altemus
Megan Altemus
C. Ryan OliverC. Ryan Oliver
C. Ryan Oliver
Brain metastases are the most lethal progression events, in part because the biological processes underpinning brain metastases are poorly understood. There is a paucity of realistic models of metastasis, as current in vivo murine models are slow to manifest metastasis. Metabolic and secretory modulators of brain metastases utilizing two models consisting of in vitro microfluidic devices are delineated: 1) a blood–brain niche (BBN) chip that recapitulates the blood–brain‐ barrier and niche; and 2) a migration chip that assesses cell migration. Secretory cues provided by the brain niche that attract metastatic cancer cells to colonize the brain niche region are reported. Astrocytic Dkk‐1 is increased in response to brain‐seeking breast cancer cells and stimulates cancer cell migration. Brain metastatic cancer cells under Dkk‐1 stimulation increase gene expression of FGF‐13 and PLCB1. Further, extracellular Dkk‐1 modulates cancer cell migration upon entering the brain niche.

2 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
C. Ryan OliverC. Ryan Oliver
C. Ryan Oliver
ALAndrew Little
Andrew Little
TWTrisha M. Westerhof
Trisha M. Westerhof
PPPragathi Pathanjeli
Pragathi Pathanjeli
JYJoel A. Yates
Joel A. Yates
SMSofia Merajver
Sofia Merajver
By combining the radial migration assay with injection molded gaskets and a rigid fixture, we have developed a more reliable and sensitive method for measuring radial cell migration. This method is well adapted for use on high throughput automated imaging systems. The use of injection molded gaskets enables low cost replacement of cell-wetted components. Furthermore, the design enables secondary placement of attractants and co-cultures. This device and high-throughput application permit the use of therapeutic screening to evaluate phenotypic responses e.g. cancer cell migration. This approach is orthogonal to other 2D cell migration applications such as scratch wound assays, although here we offer a non-invasive, high-throughput device which is currently not commercially available. Collectively, we have designed a systematic, reliable, high-throughput application to monitor phenotypic responses to chemotherapeutic screens, genetic alterations (e.g. RNAi; CRISPR; others), supplemental regiments, and other approaches offering a reliable methodology to survey unbiased and non-invasive cell migration.

12 November 2020 in SLAS Technology
Verified
Journal Article
Open access
PDF file
C. Ryan OliverC. Ryan Oliver
C. Ryan Oliver
ALAndrew C. Little
Andrew C. Little
TWTrisha M. Westerhof
Trisha M. Westerhof
PPPragathi Pathanjeli
Pragathi Pathanjeli
JYJoel A. Yates
Joel A. Yates
SMSofia Merajver
Sofia Merajver
It is often desirable to evaluate the ability of cells to move in an unrestricted manner in multiple directions without chemical gradients. By combining the standard radial migration assay with injection-molded gaskets and a rigid fixture, we have developed a highly reliable and sensitive method for observing and measuring radial cell migration. This method is adapted for use on high-throughput automated imaging systems. The use of injection-molded gaskets enables low-cost replacement of cell-wetted components. Moreover, the design enables secondary placement of attractants and co-cultures. This device and its enhanced throughput permit the use of therapeutic screening to evaluate phenotypic responses, for example, cancer cell migration response due to drugs or chemical signals. This approach is orthogonal to other 2D cell migration applications, such as scratch wound assays, although here we offer a noninvasive, enhanced-throughput device, which currently is not commercially available but is easily constructed. The proposed device is a systematic, reliable, rapid application to monitor phenotypic responses to chemotherapeutic screens, genetic alterations (e.g., RNAi and CRISPR), supplemental regimens, and other approaches, offering a reliable methodology to survey unbiased and noninvasive cell migration.